Timed Inspiratory Effort (TIE index)
DeviceConventional clinical treatment and using the Timed Inspiratory Effort (TIE index), which guided the decision to ventilate weaning and extubation.
NCT Number: NCT04512677
Mechanical ventilation (MV) is an essential therapy for patients with acute respiratory failure. The ventilatory weaning process should be started when the precipitating causes of the use of the ventilatory prosthesis are resolved. Inappropriately slow weaning exposes the patient to unnecessary discomfort, increases the risk of complications and increases the cost of hospital treatment. In this sense, indices that can predict successful weaning are of great value.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil
Mechanical ventilation (MV) is an essential therapy for patients with acute respiratory failure. The ventilatory weaning process should be started when the precipitating causes of the use of the ventilatory prosthesis are resolved. Inappropriately slow weaning exposes the patient to unnecessary discomfort, increases the risk of complications and increases the cost of hospital treatment. In this sense, indices that can predict successful weaning are of great value. Our study aimed to evaluate the performance of a new ventilatory weaning index, the timed inspiratory effort index (TIE index), as a weaning predictor in comparison with the traditionally used spontaneous breathing test (SBT). The study is a randomized controlled trial of a cohort of mechanically ventilated patients over 24 hours admitted to the ICU of Hospital e Clínica São Gonçalo (HCSG), located in the city of São Gonçalo, State of Rio de Janeiro, Brazil. The TIE index is calculated as the ratio of the maximum inspiratory pressure developed in the last 30 seconds of a 60 second period of unidirectional airway occlusion by the time required to reach this value.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion and exclusion criteria
Our study included patients over 18 years old, under mechanical ventilation, who remained for more than 24 hours of invasive ventilatory assistance and who were able to start the process of weaning. Exclusion criteria comprised tracheostomy, chronic neurological disorders, low level of alertness, and chronic immune suppression states, including positive serology for HIV.
Conventional clinical treatment and using the Timed Inspiratory Effort (TIE index), which guided the decision to ventilate weaning and extubation.
Time frame: Two years
Compare the timed inspiratory effort index parameter TIE as an indicator of weaning compared to the spontaneous breathing test
Time frame: Two years
Compare the frequency of failure at weaning when using the TIE index or the T-piece TRE as a criterion for extubation.
Time frame: Two years
Evaluate the number of tests required until the decision favorable to extubation was made in both groups.
Time frame: Two years
Compare the length of stay in the ICU between extubation, discharge or death counted from extubation among patients who used the TIE or SBT index in T piece.
Time frame: Two years
Compare the ICU mortality among patients using the TIE or TRE method in T piece
Universidade Federal Fluminense
Other
Ventilatory Weaning Guided by the Timed Inspiratory Effort Index
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06261619
Airway Management, Pathologic Processes
Providence, Rhode Island, United States
View Trial DetailsNCT03195127
Chronic Disease, Critical Illness
Baltimore, Maryland, United States
View Trial DetailsNCT02842944
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Amiens, France
View Trial DetailsNCT02723565
Acute Respiratory Failure, Pathologic Processes
Toronto, Ontario, Canada
View Trial Details